Scientists supercharge immune cells to fight advanced breast cancer
NCT ID NCT03272334
Summary
This early-phase trial is testing a two-part treatment for women whose breast cancer has spread. Doctors take a patient's own immune cells, modify them in a lab to better target cancer, and then infuse them back alongside a drug called pembrolizumab. The main goals are to find a safe dose and see if this combination can help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ashley Donihee
Charlottesville, Virginia, 22908, United States
Conditions
Explore the condition pages connected to this study.